New Products Continue To Boom
Before Document Were invited to participate in 41 sessions held in Harbin, China will new drugs and new drug made the country the fourth Cloth Will. The two meetings to the general view is that the author, at which gold content publishing and launch of new drugs was significantly higher than last year, held in Nanjing, the third conference on new drugs introduce new varieties. Although the new product formulations change, change specifications or the existence of the so-called new drugs, but some new drug or refreshing.
According to statistics, at which participants reported the chemical drugs, biological drugs, Traditional Chinese medicine And in vitro biological diagnostic reagents for various categories up to 350 or so varieties of drugs. This article will be published on the cardiovascular analysis of several varieties.
2008 over 100 billion market of Cardiovascular Drugs
Data: 2005 Urban sample Hospital The total amount of drugs purchased over the previous year increased by 19.67% year on year? But lower than the 27.58 percent growth in 2004 has decreased significantly. Samples of China's major cities according to categories of drugs used in hospitals statistics, only five classes of drugs was higher than the average. The largest increase is the anti- Cancer And Immunity Regulator, followed by nervous system drugs, respectively, respiratory medicine, blood and hemopoietic system drugs and cardiovascular drugs. The most concern is the systemic infection of drug use categories, the growth rate of only 12.78%, compared to 2004 decreased by 8.9%. Figure 1 shows the total amount of anti-infective share declining, Digestion System, the share of drug balance fine-tuning to do, while other types were tested growth.
Present, worldwide Hypertension Were 600 million people, about 10% prevalence of hypertension. Cardiovascular drug market was growing trend. Cardiovascular system Prescription drugs Market reached 75 billion U.S. dollars in 2004, is expected by 2008 more than 100 billion U.S. dollars, sales of home sales for all categories of the first drugs. Calcium antagonist treatment in which cardiovascular drugs account for about 19.2% market share, angiotensin receptor antagonist account for 18.2%, lipid-lowering drugs accounted for about 13%, -receptor blocker about 11.8%, and other drugs accounted for about 38%.
Drug brilliant stars Reported in the world pharmaceutical market has the potential treatment of cardiovascular disease, the drug total of six, all antihypertensive medication, of which four belong to angiotensin receptor antagonist.
candesartan: AstraZeneca and Takeda to jointly develop, in 2008 sales estimated at up to 20 million;
irbesartan: Bristol-Myers Squibb R & D, sales in 2008 is estimated to be 1.34 billion U.S. dollars;
Telmisartan: Boehringer Ingelheim and GlaxoSmithKline Companies to develop sales, estimated 2008 sales of up to 20 million;
olmesartan: 3 total Pharmacy The company developed in 2008 estimated sales of up to 1.324 billion U.S. dollars;
metoprolol: AstraZeneca PLC is owned by the 2008 sales estimated at up to 570 million U.S. dollars;
Ramipril: by Sanofi - Aventis development and sales, estimated sales in 2008 could reach 8.9 billion.
In addition, some composite step-down Preparation Also striking. For example, in 2004, before the world's 500 best-selling drug, Novartis sort of valsartan and valsartan 13 + hydrochlorothiazide, ranking 15 Merck's losartan potassium and losartan potassium + hydrochlorothiazide, race Nuofei - Aventis sort 95 of irbesartan and irbesartan + hydrochlorothiazide, Bristol-Myers Squibb Company ranking 101 of irbesartan + hydrochlorothiazide, sorted by Boehringer Ingelheim's for 136 meters losartan + hydrochlorothiazide; ranked 500 in 2005, the list of sales of Novartis amlodipine + benazepril, Merck's enalapril + hydrochlorothiazide and so on.
Particular Pfizer Company Benzene Acid amlodipine + atorvastatin calcium particular concern, the drug is also used to treat high blood pressure and high Cholesterol The compound preparation, in 2005 its sales reached 185 million U.S. dollars, up 272% from 2008 sales expected to reach 1.09 billion U.S. dollars.
Nearly white-hot competition in the market
Hospitals in the sample of cardiovascular drugs, there are several types of drugs cause for concern. Conference on new drugs published in the 7 drugs, cardiovascular drugs accounted for 3, 2 of which is angiotensin receptor antagonist, there is a diuretic.
Analysis of the current competitive market, three types of drugs 5 years of growth, you can find the best momentum of calcium antagonists (see Figure 2).
The many anti-hypertensive therapy, the angiotensin receptor antagonist (ARB) is the emergence of a new generation of the 90's anti-hypertension drug, a class is growing fast. Today, there are eight kinds of ARB global market, China has 5 General Name drugs used in clinical Bed . In such drugs, because the first clinical application of losartan, so the current use of the largest growth is also the best; and telmisartan and candesartan is growing faster in recent years, the ARB class of drugs (see Figure 3).
Comment Large In Small
I am an expert from China Hardware Suppliers, usually analyzes all kind of industries situation, such as hf ssb , sidekick ii cell phone.
